Abstract
Purpose/Objective: Early stage nasopharyngeal carcinoma is a radiosensitive disease with high cure rate. To reduce the radiation dose to the temporal lobes, we have decreased the dose of external radiotherapy (RT) and compensated by stereotactic radiotherapy (SRT) boost. The total treatment time was also shortened, providing a potential radiobiological benefit.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.